Ann: December 2022 Quarterly Activities and Cashflow Reports, page-20

Calm down Cyclon.
It is a common way that it takes years before an Biotech company produces anything.
I was aware of the risk as i bought Cannpal shares but i saw a big market, and i still believe that Cannabis based products will have a bright future.
Lets wait if this future happens with or without AC8.
Currently we can do nothing else than wait, pray and hope.
I guess that about 90% of Biotech Startups end in bancrupty sooner or later, we bought a Stock with high risk but also with the possibility of a high reward.
Don't let AC8 rob your sleep at night, it is not worth it.

cheers
Nauschder